What are focal seizures and how serious are they?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Are Focal Seizures and How Serious Are They?

Focal seizures are abnormal electrical discharges originating in a localized area of one brain hemisphere that can manifest with or without impaired consciousness, and they represent the most common and frequently drug-resistant form of epilepsy, affecting over 50 million people worldwide with significant implications for mortality, cognitive function, and quality of life. 1, 2

Definition and Core Characteristics

Focal seizures arise within neural networks limited to a single cerebral hemisphere, though they may subsequently spread to become more widely distributed or evolve into bilateral tonic-clonic seizures. 3, 4 The key distinguishing feature is their origin in a specific brain region rather than affecting both hemispheres simultaneously from onset. 2

Classification by Awareness Level

  • Focal aware seizures: The patient maintains consciousness throughout the episode 3
  • Focal impaired awareness seizures: Consciousness is affected, often manifesting as staring spells or unresponsiveness 3, 2
  • Focal to bilateral tonic-clonic: Seizures that start focally then propagate to both hemispheres 4, 2

Clinical Manifestations

Motor Symptoms

  • Jerking of one extremity or one side of the body 3
  • Abnormal facial movements 3
  • Small repetitive movements 3
  • Hemiparesis as the most frequent focal neurological sign 4

Non-Motor Symptoms

  • Epigastric aura: A rising sensation in the abdomen, highly characteristic of focal seizures 3
  • Olfactory hallucinations: Unusual unpleasant smells 3
  • Staring spells indicating impaired awareness 3
  • Autonomic symptoms including sweating, chills, and shivering 5
  • Sensory disturbances, visual field defects, aphasia, or psychosis depending on seizure location 4

Temporal Pattern

  • Episodes typically last longer than absence seizures (>15-30 seconds) 3
  • Post-ictal confusion or sleep commonly occurs, unlike generalized absence seizures where patients return immediately to baseline 3
  • Median delay from symptom onset to diagnosis is 7 days, highlighting diagnostic challenges 4

Severity and Prognosis

Recurrence Risk

Focal seizures have a recurrence rate up to 94%, considerably higher than generalized seizures at 72%, making them inherently more serious in terms of chronicity. 3, 4

Drug Resistance

  • Approximately 30% of patients with epilepsy do not respond to two anti-seizure medications and are considered drug-resistant, with focal epilepsies being the primary culprit. 1
  • In children and adolescents, approximately 20% develop drug resistance with risk for poor long-term cognitive and psychosocial outcomes together with poor quality of life. 1
  • Drug-resistant focal epilepsy represents the most serious form, requiring surgical evaluation. 1

Surgical Outcomes

  • When epilepsy surgery is performed for drug-resistant focal epilepsy, approximately 65% of patients become seizure-free. 1
  • Surgery is overall safe, successful, and cost-effective when the epileptogenic zone is correctly detected and located outside eloquent brain areas. 1

Underlying Causes and Structural Associations

Adults

  • Hippocampal sclerosis is the most common cause of temporal lobe focal seizures 6
  • Acquired structural lesions including stroke and cerebral infarction 6
  • Brain tumors, particularly low-grade epilepsy-associated tumors 6
  • Vascular malformations 6
  • Infections 6
  • Traumatic brain injury 2

Children

  • Malformations of cortical development (MCD) are the most common cause of medically refractory focal epilepsy 6
  • Focal cortical dysplasia (FCD) is the most frequent MCD subtype 6
  • Birth-related lesions including perinatal stroke or hemorrhages 6
  • Polymicrogyria and hemimegalencephaly 6

High-Risk Indicators

  • Presence of focal neurologic examination findings has 97% correlation with symptomatic seizures 6
  • Approximately 4% of children with first-time afebrile focal seizures have urgent intracranial pathology, most commonly infarction, hemorrhage, and thrombosis 4

Diagnostic Approach

Neuroimaging Requirements

  • MRI is the imaging study of choice for all patients with focal seizures, with detection rates up to 55% in children and sensitivity of 84% for intractable seizures. 3, 6
  • Dedicated epilepsy protocols with 3T scanners using T1-weighted volumetric acquisition with 1mm isotropic voxels and high-resolution coronal slices optimized for hippocampal pathology are recommended. 4
  • MRI detected abnormalities not identified by CT in 47% of children with focal seizures. 4
  • Non-contrast CT has a role only in emergent acute seizures to rapidly identify hemorrhage, stroke, or tumors requiring immediate intervention. 4

Electrophysiology

  • EEG should be obtained, showing ictal discharges originating from one hemisphere in focal seizures 4
  • A normal interictal EEG cannot rule out epilepsy and must be interpreted in clinical context 3
  • Video EEG monitoring may be necessary to capture ictal events for definitive diagnosis 7

Laboratory Evaluation

  • Check glucose in all patients with focal features, as hypoglycemia can present with focal neurologic deficits 4
  • Glucose abnormalities and hyponatremia are the most frequent metabolic abnormalities in patients with focal neurologic deficits 4

Treatment Implications

First-Line Pharmacotherapy

  • Carbamazepine, phenytoin, or valproic acid are often rated as first-line drugs 7
  • Among newer anti-seizure medications, lamotrigine, gabapentin, topiramate, and oxcarbazepine have monotherapy indications 7
  • Level A evidence for initial monotherapy is available for seven drugs with no robust data supporting superiority of one over another 8
  • Cenobamate represents the latest approved option for focal seizures 8

Surgical Evaluation Pathway

  • Patients with focal epilepsy who become drug-resistant after failing two appropriate anti-seizure medications should promptly undergo assessment in an epilepsy center 2
  • Presurgical evaluation includes scalp video/EEG telemetry, structural MRI, neuropsychological assessment, functional MRI, interictal [18F]FDG PET, and ictal perfusion SPECT 1
  • These functional imaging tools are especially useful in non-lesional epilepsy or multifocal structural abnormalities to localize the seizure onset for tailored resection 1

Critical Pitfalls to Avoid

  • Do not dismiss epigastric sensations as "just anxiety" or gastrointestinal symptoms, as this is a characteristic aura of focal seizures 3
  • Do not confuse brief post-ictal sleep with normal tiredness after a stressful event, as this indicates a seizure occurred 3
  • Do not assume a normal interictal EEG rules out epilepsy; clinical diagnosis takes precedence 3
  • Do not rely solely on CT imaging, as it misses small cortical lesions and has much lower sensitivity than MRI for epileptogenic foci 6
  • The diagnosis of focal status epilepticus is often delayed or missed and should be considered after strokes or clinical seizures when patients do not stabilize or improve as expected 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Focal epilepsies: Update on diagnosis and classification.

Epileptic disorders : international epilepsy journal with videotape, 2023

Guideline

Focal Seizure with Impaired Awareness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Seizure Classification and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.